Stem Cell Assay Market Size, Share, Growth Analysis, By Product(Microelectrode arrays, flow cytometers, cell imaging systems, automated cell counters), By Application(Orthopedic & musculoskeletal spine, dermatology, cardiovascular, central nervous system), By End user(Biotechnology industries, research organizations, academic institutes, and others), By Assay(Cell viability & toxicity assays, cell identification assays, cell proliferation assays, cell apoptosis assays), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2123 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 125 |Figures: 77

Stem Cell Assay Market Insights

Stem Cell Assay Market size was valued at USD 1 billion in 2022 and is poised to grow from USD 1.04 billion in 2023 to USD 1.44 billion by 2031, at a CAGR of 4.2 % during the forecast period (2024-2031).

The adoption of stem cell assays is supported by their ability to provide a consistent supply of hard-to-source cell types and create physiologically relevant models. Advancements in medical infrastructure and the introduction of new technologies have contributed to the growth of the stem cell assay market.

These advancements have revolutionized treatment procedures and led to the discovery of new treatments and generic medicines. Cell-based assays are commonly used to assess cell viability, cytotoxicity, senescence, and other parameters, especially in high-throughput screening formats.

Increased funding and research efforts in stem cell assays have fueled advancements in safe treatment options. The growing demand for stem cell-based assays in medical research and drug discovery, as well as the expansion of pharmaceutical industries, have also contributed to the growth of the cell-based assay market.

US Stem Cell Assay Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 957 million

Largest Segment

biotechnology industries

Fastest Growth

biotechnology industries

Growth Rate

4.2% CAGR

Global stem cell assay market by region
Country Share for North America (%)

To get more reports on the above market click here to Buy The Report

Stem Cell Assay Market Segmental Analysis

The stem cell assay market is segmented based on product, application, assay, end-user, and region. The product segment includes microelectrode arrays, flow cytometers, cell imaging systems, automated cell counters, kits, and others. The assay segment consists of cell viability & toxicity assays, cell identification assays, cell proliferation assays, cell apoptosis assays, and others. Applications in the market include orthopedic & musculoskeletal spine, dermatology, cardiovascular, central nervous system, and others. The market’s end-users are biotechnology industries, research organizations, academic institutes, and others. Regions covered are Asia-Pacific, Europe, North America, South America, and Middle East & Africa.

Stem Cell Assay Market Analysis By Product

The largest segment in the stem cell assay market is likely to be the consumables and reagents segment. Consumables and reagents are essential components in stem cell assays, as they are required for the preparation, culture, and analysis of stem cells. The demand for consumables and reagents is driven by the growing adoption of stem cell-based therapies and the increasing focus on drug screening and toxicity testing using stem cell models.

The fastest-growing segment in the stem cell assay market is expected to be the instruments segment. The increasing investment in research and development activities related to stem cells, along with the rising demand for automated and high-throughput screening systems, is driving the growth of the instruments segment in the stem cell assay market.

Stem Cell Assay Market Analysis By Application

Regenerative medicine is a rapidly growing application area for stem cell assays. Stem cells have the potential to differentiate into various cell types, making them promising tools for tissue engineering and regenerative medicine. Stem cell assays are used in cancer research to study the behavior and characteristics of cancer stem cells (CSCs). CSCs are a subset of cancer cells that possess stem cell-like properties and are associated with tumor initiation, progression, and resistance to therapy.

Global stem cell assay market by end-user

To get detailed analysis on other segments, Request For Free Sample Report

Stem Cell Assay Market Regional Insights

North America has been a significant market for stem cell assays, primarily driven by the presence of advanced healthcare infrastructure, a robust research and development sector, and favorable government initiatives. The United States, in particular, has been a key player in this region, housing several major pharmaceutical and biotechnology companies that invest heavily in stem cell research.

Europe has also been a prominent region in the stem cell assay market, with countries like Germany, the United Kingdom, and France at the forefront. The region's strong focus on healthcare advancements, increasing research funding, and supportive regulations have contributed to the growth of the market. The Asia Pacific region has witnessed significant growth in the stem cell assay market. Countries such as China, Japan, and India have made substantial investments in stem cell research, resulting in the establishment of advanced research facilities and a growing number of research publications. The region's large population and increasing healthcare expenditure also contribute to the market's expansion.

Global stem cell assay market by geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Stem Cell Assay Market Dynamics

Stem Cell Assay Market Drivers

Increasing Health Awareness

  • The growth of the global stem cell assay market has traditionally been driven by factors such as population growth and increasing health awareness. However, the market faced challenges during the pandemic as several sectors experienced a downturn. Despite this, key market drivers in the industry have remained resilient and continued to offer their products. While managing the global demand can be challenging, the advancements in stem cell assays have provided some benefits for patients.

Stem Cell Assay Market Restraints

High Cost of Raw Materials

  • It is important to note that the high cost of raw materials has posed challenges for certain industrial sectors, making it difficult for them to sustain production operations.

Request Free Customization of this report to help us to meet your business objectives.

Stem Cell Assay Market Competitive Landscape

The global stem cell assay market is characterized by intense competition among key players. The market is highly fragmented, with numerous companies vying for market share. These companies are focusing on strategic initiatives such as mergers and acquisitions, partnerships, and collaborations to strengthen their market position. They are also investing heavily in research and development activities to introduce innovative and technologically advanced stem cell assays. Furthermore, companies are actively engaging in product launches and expansions to cater to the growing demand for stem cell assays across various research and clinical applications. They are also emphasizing expanding their distribution networks and reaching out to untapped markets to enhance their global presence.

Stem Cell Assay Market Top Player’s Company Profiles

  • Thermo Fisher Scientific Inc. (United States)
  • PerkinElmer, Inc. (United States)
  • BD Biosciences (United States)
  • Promega Corporation (United States)
  • Lonza Group Ltd. (Switzerland)
  • Miltenyi Biotec (Germany)
  • Cell Biolabs, Inc. (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • R&D Systems, Inc. (United States)
  • Abcam plc (United Kingdom)
  • Agilent Technologies, Inc. (United States)
  • Bio-Techne Corporation (United States)
  • Cisbio Bioassays (France)
  • Essen BioScience (United States)
  • Cell Signaling Technology, Inc. (United States)
  • Charles River Laboratories International, Inc. (United States)
  • Sysmex Corporation (Japan)

Stem Cell Assay Market Recent Developments

  • In September 2022 Century Therapeutics and Bristol Myers Squibb announced a license agreement and research collaboration for the development and commercialization of iPSC-derived allogeneic cell therapies.

Stem Cell Assay Key Market Trends

  • There is a growing focus on personalized medicine and regenerative therapies, which has led to an increased demand for stem cell assays to support drug discovery and development processes. Additionally, advancements in technology and automation have enhanced the efficiency and accuracy of stem cell assays, leading to improved research outcomes and reduced costs.

Stem Cell Assay Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our analysis, the global stem cell assay market holds promising future prospects due to the increasing research activities and advancements in stem cell-based therapies. There is a rising interest in using stem cell assays for toxicology testing and safety assessment, particularly in the pharmaceutical and cosmetic industries, to replace animal testing methods. Furthermore, collaborations and partnerships between academic institutions, research organizations, and pharmaceutical companies are driving innovation in stem cell assay development. Lastly, the increasing prevalence of chronic diseases and the aging population worldwide are expected to fuel the demand for stem cell assays in disease modeling and regenerative medicine applications.

Report Metric Details
Market size value in 2022 USD 1 billion
Market size value in 2031 USD 1.44 billion
Growth Rate 4.2%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product
    • Microelectrode arrays, flow cytometers, cell imaging systems, automated cell counters, kits, and others
  • Application
    • Orthopedic & musculoskeletal spine, dermatology, cardiovascular, central nervous system, and others
  • End user
    • Biotechnology industries, research organizations, academic institutes, and others
  • Assay
    • Cell viability & toxicity assays, cell identification assays, cell proliferation assays, cell apoptosis assays, and others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Thermo Fisher Scientific Inc. (United States)
  • PerkinElmer, Inc. (United States)
  • BD Biosciences (United States)
  • Promega Corporation (United States)
  • Lonza Group Ltd. (Switzerland)
  • Miltenyi Biotec (Germany)
  • Cell Biolabs, Inc. (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • R&D Systems, Inc. (United States)
  • Abcam plc (United Kingdom)
  • Agilent Technologies, Inc. (United States)
  • Bio-Techne Corporation (United States)
  • Cisbio Bioassays (France)
  • Essen BioScience (United States)
  • Cell Signaling Technology, Inc. (United States)
  • Charles River Laboratories International, Inc. (United States)
  • Sysmex Corporation (Japan)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Stem Cell Assay Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Stem Cell Assay Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Stem Cell Assay Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Stem Cell Assay Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Stem Cell Assay Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Stem Cell Assay Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Stem Cell Assay Market size was valued at USD 1 billion in 2022 and is poised to grow from USD 1.04 billion in 2023 to USD 1.44 billion by 2031, at a CAGR of 4.2 % during the forecast period (2024-2031).

The global stem cell assay market is characterized by intense competition among key players. The market is highly fragmented, with numerous companies vying for market share. These companies are focusing on strategic initiatives such as mergers and acquisitions, partnerships, and collaborations to strengthen their market position. They are also investing heavily in research and development activities to introduce innovative and technologically advanced stem cell assays. Furthermore, companies are actively engaging in product launches and expansions to cater to the growing demand for stem cell assays across various research and clinical applications. They are also emphasizing expanding their distribution networks and reaching out to untapped markets to enhance their global presence. 'Thermo Fisher Scientific Inc. (United States)', 'Merck KGaA (Germany)', 'GE Healthcare (United States)', 'PerkinElmer, Inc. (United States)', 'BD Biosciences (United States)', 'STEMCELL Technologies Inc. (Canada)', 'Promega Corporation (United States)', 'Lonza Group Ltd. (Switzerland)', 'Miltenyi Biotec (Germany)', 'Cell Biolabs, Inc. (United States)', 'Bio-Rad Laboratories, Inc. (United States)', 'R&D Systems, Inc. (United States)', 'Abcam plc (United Kingdom)', 'Agilent Technologies, Inc. (United States)', 'Bio-Techne Corporation (United States)', 'Cisbio Bioassays (France)', 'Essen BioScience (United States)', 'Cell Signaling Technology, Inc. (United States)', 'Charles River Laboratories International, Inc. (United States)', 'Sysmex Corporation (Japan)'

The growth of the global stem cell assay market has traditionally been driven by factors such as population growth and increasing health awareness. However, the market faced challenges during the pandemic as several sectors experienced a downturn. Despite this, key market drivers in the industry have remained resilient and continued to offer their products. While managing the global demand can be challenging, the advancements in stem cell assays have provided some benefits for patients.

There is a growing focus on personalized medicine and regenerative therapies, which has led to an increased demand for stem cell assays to support drug discovery and development processes. Additionally, advancements in technology and automation have enhanced the efficiency and accuracy of stem cell assays, leading to improved research outcomes and reduced costs.

North America has been a significant market for stem cell assays, primarily driven by the presence of advanced healthcare infrastructure, a robust research and development sector, and favorable government initiatives. The United States, in particular, has been a key player in this region, housing several major pharmaceutical and biotechnology companies that invest heavily in stem cell research.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Stem Cell Assay Market

Report ID: SQMIG35H2123

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE